IsoRay Inc Valuation
ISRDelisted Stock | USD 0.38 0.01 2.70% |
IsoRay seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of IsoRay Inc from evaluating the firm fundamentals such as Return On Asset of -0.11, current valuation of (11.02 M), and Return On Equity of -0.17 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that IsoRay's price fluctuation is very steady at this time. Calculation of the real value of IsoRay Inc is based on 3 months time horizon. Increasing IsoRay's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the IsoRay stock is determined by what a typical buyer is willing to pay for full or partial control of IsoRay Inc. Since IsoRay is currently traded on the exchange, buyers and sellers on that exchange determine the market value of IsoRay Stock. However, IsoRay's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 0.38 | Real 0.3 | Hype 0.38 |
The intrinsic value of IsoRay's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence IsoRay's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of IsoRay Inc helps investors to forecast how IsoRay stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of IsoRay more accurately as focusing exclusively on IsoRay's fundamentals will not take into account other important factors: IsoRay Total Value Analysis
IsoRay Inc is currently projected to have company total value of (11.02 M) with market capitalization of 107 M, debt of 0, and cash on hands of 55.89 M. The negative valuation of IsoRay may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial commitments of the company both on and off balance sheet. Investors should carefully check all of the IsoRay fundamentals.Takeover Price | Market Cap | Debt Obligations | Cash |
(11.02 M) | 107 M | 0 | 55.89 M |
IsoRay Investor Information
The company has price-to-book (P/B) ratio of 0.74. Some equities with similar Price to Book (P/B) outperform the market in the long run. IsoRay Inc recorded a loss per share of 0.04. The entity last dividend was issued on the 29th of October 2010. The firm had 1:30 split on the 17th of August 2005. Based on the key measurements obtained from IsoRay's financial statements, IsoRay Inc is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.IsoRay Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. IsoRay has an asset utilization ratio of 16.75 percent. This connotes that the Company is making $0.17 for each dollar of assets. An increasing asset utilization means that IsoRay Inc is more efficient with each dollar of assets it utilizes for everyday operations.IsoRay Ownership Allocation
IsoRay Inc has a total of 278.66 Million outstanding shares. Roughly 93.06 (percent) of IsoRay outstanding shares are held by general public with 0.76 % owned by insiders and only 6.18 pct. by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.IsoRay Profitability Analysis
The company reported the last year's revenue of 10.79 M. Reported Net Loss for the year was (7.27 M) with profit before taxes, overhead, and interest of 4.62 M.About IsoRay Valuation
The delisted stock valuation mechanism determines IsoRay's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of IsoRay Inc based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of IsoRay. We calculate exposure to IsoRay's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of IsoRay's related companies.Isoray, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. Isoray, Inc. was founded in 1998 and is based in Richland, Washington. Isoray operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 66 people.
IsoRay Growth Indicators
Investing in growth stocks can be very risky. If the company such as IsoRay does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding | 142 M | |
Retained Earnings | -98.6 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in IsoRay Stock
If you are still planning to invest in IsoRay Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IsoRay's history and understand the potential risks before investing.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |